Seeking Alpha HealthcareOriginal article
Schrödinger outlines $218M-$228M 2026 ACV outlook with focus on hosted transition and Bunsen early access release
EarningsBunsenPositive
AI Analysis
Summary
Schrödinger provided 2026 annual contract value (ACV) guidance of $218M-$228M, highlighting focus on hosted transition and Bunsen early access release.
Financial Highlights
Guidance
$218M-$228M 2026 ACV outlook
Importance:5/10
Sentiment:
0.50
guidancerevenue_outlookproduct_transitionearly_access
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on May 6, 2026 12:23 AM